| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3329366 | Critical Reviews in Oncology/Hematology | 2011 | 18 Pages |
Abstract
Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. Molecular imaging using positron emission tomography (PET) is now an integral part of multidisciplinary cancer care. In this review, we discuss the role of PET in CRC including well established indications in the assessment of recurrent disease and emerging applications such as initial staging, monitoring therapy efficacy and using PET for radiotherapy planning. With rapid advancement in imaging technology, we also discuss the future potential of combining PET and magnetic resonance imaging and the use of novel radiotracers.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Michael Lin, Karen Wong, Weng Leong Ng, Ivan Ho Shon, Matthew Morgan,